Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma

[1]  Wenwei Cheng,et al.  Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer , 2022, Cancer Cell International.

[2]  Jing Zhao,et al.  Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma , 2022, Apoptosis.

[3]  X. Qiu,et al.  Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer , 2022, Frontiers in Immunology.

[4]  Chuanbin Yang,et al.  LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15. , 2022, Pathology, research and practice.

[5]  Ben Ma,et al.  Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC , 2022, Frontiers in Genetics.

[6]  X. Qin,et al.  SPINK5 is a Prognostic Biomarker Associated With the Progression and Prognosis of Laryngeal Squamous Cell Carcinoma Identified by Weighted Gene Co-Expression Network Analysis , 2022, Evolutionary bioinformatics online.

[7]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[8]  A. Moming,et al.  Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma , 2021, Bioengineered.

[9]  Ayushi Sharma,et al.  Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma. , 2021, Biochimica et biophysica acta. Molecular basis of disease.

[10]  U. Şahin,et al.  Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient , 2021, International journal of molecular sciences.

[11]  Hua Yuan,et al.  The Identification of Stemness-Related Genes in the Risk of Head and Neck Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[12]  R. Greil,et al.  Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma , 2021, International journal of molecular sciences.

[13]  N. Muhanna,et al.  Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy , 2021, The Annals of otology, rhinology, and laryngology.

[14]  B. Jeremic,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  G. Zhu,et al.  Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices , 2020, Expert review of gastroenterology & hepatology.

[16]  Wendong Wang,et al.  Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer , 2020, Frontiers in Molecular Biosciences.

[17]  Daming Liu,et al.  Long noncoding RNAs in head and neck squamous cell carcinoma: biological functions and mechanisms , 2020, Molecular Biology Reports.

[18]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[19]  Yoshimi Anzai,et al.  Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[20]  Zhen Wang,et al.  Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment , 2020, Cancer medicine.

[21]  J. T. Tseng,et al.  mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers , 2020, Genes.

[22]  S. Qin,et al.  Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma , 2019, Cancer investigation.

[23]  S. Tran,et al.  Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. , 2019, Carcinogenesis.

[24]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[25]  J. Meléndez-Zajgla,et al.  The emerging role of lncRNAs in the regulation of cancer stem cells , 2018, Cellular Oncology.

[26]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[27]  Amy Y. Chen,et al.  Epidemiology and Demographics of the Head and Neck Cancer Population. , 2018, Oral and maxillofacial surgery clinics of North America.

[28]  K. Harrington,et al.  Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. , 2018, Oral oncology.

[29]  Joshua M. Stuart,et al.  Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. , 2018, Cell.

[30]  F. Bertucci,et al.  A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability , 2017, Nature Medicine.

[31]  R. Kolamunnage-Dona,et al.  Time-dependent ROC curve analysis in medical research: current methods and applications , 2017, BMC Medical Research Methodology.

[32]  Jinxiu Lu,et al.  Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling. , 2017, Biochemical and biophysical research communications.

[33]  R. Kimura,et al.  Contribution of FGFR1 Variants to Craniofacial Variations in East Asians , 2017, PloS one.

[34]  Z. Werb,et al.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.

[35]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[36]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[37]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[38]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[39]  R. Roesler,et al.  Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. , 2014, Neoplasia.

[40]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[41]  Ho‐Seong Han,et al.  Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers. , 2013, Journal of hepatology.

[42]  C. Figdor,et al.  Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy , 2013, Oncoimmunology.

[43]  F. Bray,et al.  Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. , 2012, European journal of cancer.

[44]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[45]  L. Nicholson,et al.  Cancer stem cells: problems for therapy? , 2011, The Journal of pathology.

[46]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[47]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[48]  A. van Daal,et al.  Linkage disequilibrium analysis identifies an FGFR1 haplotype-tag SNP associated with normal variation in craniofacial shape. , 2005, Genomics.

[49]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.